Back to Search
Start Over
OnabotulinumtoxinA in urinary incontinence: Prospective study of a case series
- Source :
- Actas Urológicas Españolas (English Edition). 41:458-464
- Publication Year :
- 2017
- Publisher :
- Elsevier BV, 2017.
-
Abstract
- Objective To assess the safety and efficacy of a single intravesical injection of onabotulinumtoxinA (OnaBTA) for treating urge urinary incontinence (UUI) in women. Method We performed a prospective case-series study of consecutive patients with refractory UUI treated with an intravesical injection of OnaBTA. The patients were administered 100 units of OnaBTA injected into the bladder wall following 4 weeks of flushing with anticholinergic agents or beta-3 agonists. The urodynamic and clinical endpoints were evaluated before and 6 months after the injection of OnaBTA. The primary study endpoint was the number of episodes of urinary leakage. Results A total of 204 of the 210 selected patients conducted a valid visit 6 months after the therapeutic application. At 6 months of treatment with OnaBTA, 110 (53.9%) patients remained continent and were considered a success. However, 57 (27.9%) patients experienced one episode of urinary leakage per day, and 37 (18.2%) had 2 or more. In terms of the urodynamic parameters, we observed the following changes: increase in maximum bladder capacity ( p p Conclusions This study supports the use of OnabotulinumtoxinA in patients with urge urinary incontinence that does not respond to medical treatment.
- Subjects :
- medicine.medical_specialty
Medical treatment
business.industry
Urge urinary incontinence
030232 urology & nephrology
Urology
Urinary incontinence
General Medicine
Anticholinergic agents
03 medical and health sciences
0302 clinical medicine
Urinary Leakage
Refractory
030220 oncology & carcinogenesis
Anesthesia
Clinical endpoint
medicine
medicine.symptom
business
Prospective cohort study
Subjects
Details
- ISSN :
- 21735786
- Volume :
- 41
- Database :
- OpenAIRE
- Journal :
- Actas Urológicas Españolas (English Edition)
- Accession number :
- edsair.doi...........5e5d39e9b5d14611ea7b4f9e9bdf41c7